We are live on
!
Find out more
HR
Hardy Reed Portfolio holdings
AUM
$1.56B
1-Year Est. Return
23.01%
This Fund
S&P 500
This Quarter
Est. Return
+0.99%
1 Year Est. Return
+23.01%
3 Year Est. Return
+69.67%
5 Year Est. Return
+64.42%
10 Year Est. Return
–
AUM
$1.13B
AUM Growth
+$18.4M
(+1.6%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
66.26%
Holding
264
New
21
Increased
65
Reduced
65
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.95M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$3.83M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$3.72M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.46M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.58M |
| 2 |
Elevance Health
ELV
|
+$1.5M |
| 3 |
American Tower
AMT
|
+$1.47M |
| 4 |
Lear
LEA
|
+$1.31M |
| 5 |
Adobe
ADBE
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 70.02% |
| 2 | Financials | 13.52% |
| 3 | Technology | 7% |
| 4 | Industrials | 2.27% |
| 5 | Communication Services | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Gilead Sciences
GILD
$183B
| – | – |
-4,504
| Closed | -$378K |
|
252
Gentex
GNTX
$4.7B
| – | – |
-6,863
| Closed | -$204K |
|
|
IPG
253
DELISTED
Interpublic Group of Companies
IPG
| – | – |
-6,420
| Closed | -$203K |
|
|
254
Lear
LEA
$6.08B
| – | – |
-12,000
| Closed | -$1.31M |
|
255
Mondelez International
MDLZ
$79.6B
| – | – |
-11,511
| Closed | -$848K |
|
256
Novanta
NOVT
$5.02B
| – | – |
-1,180
| Closed | -$211K |
|
257
Pfizer
PFE
$157B
| – | – |
-11,133
| Closed | -$322K |
|
258
Restaurant Brands International
QSR
$26.1B
| – | – |
-2,776
| Closed | -$200K |
|
259
RB Global
RBA
$15.6B
| – | – |
-3,246
| Closed | -$261K |
|
260
Schwab US TIPS ETF
SCHP
$15.9B
| – | – |
-13,206
| Closed | -$354K |
|
261
Transcat
TRNS
$783M
| – | – |
-1,815
| Closed | -$219K |
|
262
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.95B
| – | – |
-4,991
| Closed | -$223K |
|
|
EXE
263
Expand Energy Corp
EXE
$20.5B
| – | – |
-3,479
| Closed | -$286K |
|
|
ENLC
264
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| – | – |
-25,590
| Closed | -$371K |
|
Similar funds
PTC
HAM
HRES
PEGL
FFM
MSFS
SC
CCFM
Hardy Reed's Q4 2024 Portfolio in Review
As of Q4 2024, Hardy Reed held 264 positions worth $1.13B, up 1.6% from $1.12B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Hardy Reed's Q4 2024 filing shows 21 new, 65 increased, 65 reduced and 18 closed positions. Its largest new stake was iShares US Healthcare ETF: 37,000 shares worth $2.16M. The largest sale was Advanced Micro Devices, an estimated $1.58M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, down from 70% a quarter earlier, followed by Financials and Technology.
- Hardy Reed's largest Q4 2024 buy was iShares US Healthcare ETF: 37,000 shares worth $2.16M.
- Hardy Reed added most to iShares Core MSCI Total International Stock ETF in Q4 2024, an estimated $4.95M increase.
- Hardy Reed's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $1.5M.
- Hardy Reed fully exited Advanced Micro Devices in Q4 2024, selling an estimated $1.58M.
- Hardy Reed's ten largest holdings make up 66% of its $1.13B portfolio in Q4 2024.
- Hardy Reed opened 21 new positions and closed 18 in Q4 2024.
- Hardy Reed's portfolio value rose 1.6% quarter-over-quarter to $1.13B.
Based on Hardy Reed's 13F filing for Q4 2024, filed 3 Feb 2025.